Trend 1 | Trend 2 | Trend 3 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Year | APC | p value | Year | APC | p value | Year | APC | p value | |||
Dermatomyositis, both sexes | |||||||||||
UCD | 1981–1982 to 1985–1986 | − 6.7% | 0.046 | 1985–1986 to 2003–2004 | − 0.1% | 0.681 | 2003–2004 to 2019–2020 | − 0.1% | < 0.001 | ||
MCD | 1981–1982 to 2003–2004 | − 1.2% | < 0.001 | 2003–2004 to 2015–2016 | − 2.5% | < 0.001 | 2015–2016 to 2019–2020 | 2.8% | 0.256 | ||
Dermatomyositis, males | |||||||||||
UCD | 1981–1982 to 2019–2020 | − 1.2% | < 0.001 | ||||||||
MCD | 1981–1982 to 2019–2020 | − 1.9% | < 0.001 | ||||||||
Dermatomyositis, females | |||||||||||
UCD | 1981–1982 to 1989–1990 | − 3.6% | 0.037 | 1989–1990 to 2003–2004 | 0.7% | 0.448 | 2003–2004 to 2019–2020 | − 2.4% | 0.001 | ||
MCD | 1981–1982 to 2003–2004 | − 0.7% | 0.021 | 2003–2004 to 2013–2014 | − 2.8% | 0.048 | 2013–2014 to 2019–2020 | 0.4% | 0.842 | ||
Polymyositis, both sexes | |||||||||||
UCD | 1981–1982 to 1989–1990 | 1.9% | 0.105 | 1989–1990 to 2005–2006 | − 2.3% | < 0.001 | 2005–2006 to 2019–2020 | − 5.2% | < 0.001 | ||
MCD | 1981–1982 to 1991–1992 | 1.3% | 0.115 | 1991–1992 to 2019–2020 | − 4.1% | < 0.001 | |||||
Polymyositis, males | |||||||||||
UCD | 1981–1982 to 1999–2000 | − 0.7% | 0.262 | 1999–2000 to 2019–2020 | − 4.6% | < 0.001 | |||||
MCD | 1981–1982 to 1991–1992 | 0.3% | 0.779 | 1991–1992 to 2019–2020 | − 4.3% | < 0.001 | |||||
Polymyositis, females | |||||||||||
UCD | 1981–1982 to 1999–2000 | − 0.3% | 0.622 | 1999–2000 to 2019–2020 | − 4.7% | < 0.001 | |||||
MCD | 1981–1982 to 1991–1992 | 1.9% | 0.083 | 1991–1992 to 2019–2020 | − 4.0% | < 0.001 |